Your Mounjaro price guide · November 2026
Weight Loss Injection Eligibility in the UK: Who Can Get Them? (November 2026)
Privately, Mounjaro and Wegovy are licensed for adults with a BMI of 30 or above, or 27 to under 30 with at least one weight-related condition, alongside a reduced-calorie diet and more physical activity. On the NHS the criteria are tighter: NICE recommends Mounjaro for adults with a BMI of at least 35 plus at least one weight-related condition, and the rollout is starting with the highest-need groups. A prescriber always makes the final decision.

From your first consultation to ongoing care.
- GPhC-registered UK pharmacy
- Prescriber assessment
- Temperature-controlled delivery
- Advice from our pharmacy team
Eligibility in one line
Privately: adult, BMI 30+ or 27+ with a weight-related condition. NHS: tighter criteria, phased in.
- Price includes prescriber assessment and standard delivery — no consultation fees
- Orders approved by 3pm for next-day tracked delivery
- GPhC-registered pharmacy 9012878
- Needles and sharps disposal included
Thinking about treatment? Read about our weight loss service
A quick overview
What to know
before you start.
-
Private licence: adults with a BMI of 30+, or 27 to under 30 with a weight-related condition.
-
Weight-related conditions include high blood pressure, high cholesterol, sleep apnoea, cardiovascular disease, prediabetes and type 2 diabetes.
-
NHS: NICE recommends Mounjaro for a BMI of at least 35 plus a weight-related condition, with highest-need groups first.
-
Not for use in pregnancy; extra care is needed with some conditions, such as a history of pancreatitis.
-
A GPhC-registered prescriber reviews every consultation and decides whether treatment is suitable.
In this guide
01 · Private criteria
Who can get weight loss injections privately?
Mounjaro is licensed for weight management in adults with a BMI of 30 or above, or a BMI between 27 and 30 with at least one weight-related condition such as high blood pressure, high cholesterol, obstructive sleep apnoea, cardiovascular disease, prediabetes or type 2 diabetes.3 Wegovy has the same BMI criteria.6 Both are used alongside a reduced-calorie diet and more physical activity.
| Your BMI | Private licence |
|---|---|
| 30 or above | Within the licence |
| 27 to under 30 | Within the licence if you have at least one weight-related condition |
| Under 27 | Outside the licence |
02 · Next step
Checking if treatment is right for you
Start the free consultation from our Mounjaro or Wegovy page. You answer questions about your health, weight and medicines, and a GPhC-registered prescriber reviews them. If treatment is not suitable, you get an automatic full refund. Mounjaro and Wegovy are prescription-only medicines, supplied only after an online consultation reviewed by a GPhC-registered prescriber. This page is information, not a substitute for medical advice.
03 · Working out your BMI
Working out your BMI
Body mass index (BMI) is your weight in kilograms divided by your height in metres squared. For example, someone who weighs 95kg and is 1.70m tall has a BMI of about 32.9. BMI is a screening measure, not a full picture of health, and the prescriber looks at your answers as a whole.
For people from some ethnic backgrounds, including South Asian, Chinese, other Asian, Middle Eastern, Black African and African-Caribbean backgrounds, NICE uses lower BMI thresholds, because health risks rise at a lower BMI.1
04 · NHS criteria
Who can get weight loss injections on the NHS?
NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first, initially BMI 40+ with four or more qualifying conditions.12 Mounjaro is available on the NHS, but access is being phased in over several years, so many people who meet the NICE criteria are not yet able to get it.
If you think you may qualify, speak to your GP. On the NHS you pay the standard prescription charge in England, and prescriptions are free in Scotland, Wales and Northern Ireland.
05 · Who should not use them
Who should not use weight loss injections
- Under 18s: these medicines are licensed for weight management in adults.
- Pregnancy: Mounjaro should not be used in pregnancy. Tell the prescriber if you are pregnant, trying to conceive or breastfeeding.
- Allergy: anyone allergic to the medicine or its ingredients.
Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems.3 Always give full, accurate answers in your consultation, including every medicine you take.
06 · Contraception
If you use the contraceptive pill
Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed.4 Use a barrier method or switch to a non-oral method for four weeks after starting and for four weeks after each dose increase.3
07 · Other medicines
Other medicines and conditions
If you take insulin or a sulfonylurea for diabetes, the prescriber may need to adjust your treatment, because the risk of low blood sugar is higher.3 Never take two weight-loss medicines of this type together. If you already take Mounjaro or Wegovy from another provider, tell us your current dose and when you last injected.
08 · Which injection
Which injection might suit you?
If you are eligible, the main choice is between Mounjaro and Wegovy. In the head-to-head SURMOUNT-5 trial, tirzepatide gave 20.2% average weight loss over 72 weeks versus 13.7% for semaglutide 2.4mg.5 Wegovy is usually cheaper. If you would rather not inject, Wegovy tablets and Foundayo are licensed GLP-1 tablets. Our pages on Mounjaro vs Wegovy, what injections cost and the best weight loss pills can help you decide.
How ordering works
How ordering works at EverydayMeds
Three steps, with our pharmacy team alongside you.
Step 1: Online consultation — 5–10 minutes
Complete a confidential health questionnaire covering BMI, medical history and current medication. No payment is taken until you're approved.
Step 2: Prescriber review — usually same day
A UK registered prescriber checks your suitability against the licensed criteria (BMI ≥30, or ≥27 with a weight-related condition) and contraindications, and confirms your starting dose.
Step 3: Next-day tracked delivery
Dispensed by our GPhC-registered pharmacy in temperature-controlled packaging with needles and a sharps bin included. Orders approved by 3pm for next-day tracked delivery.
Prescription and dispatch follow clinical approval. Confirm current delivery options when ordering.
Afterwards you're not on your own: dose-change reviews are built in before each step up, our pharmacist team is available for side-effect questions, and repeat orders re-check suitability rather than auto-shipping.
Your questions, answered
Frequently asked questions
Answers to common questions about Mounjaro, NHS access and ongoing treatment.
Ask our pharmacy teamWho is eligible for weight loss injections in the UK?
Can I get Mounjaro with a BMI of 27?
Can I get weight loss injections on the NHS?
What counts as a weight-related condition?
Can I use weight loss injections if I am pregnant?
What happens if I am not eligible?

Clinically reviewed by
Mahommed Zunaid Ayub Patel
Superintendent Pharmacist
Accountable for the safe running of our registered pharmacy — from dispensing checks to delivery.
GPhC registration no. 2217101 · check the GPhC register
- Reviewed
- Last updated
- Next review
How we source our information
How we source our information: every clinical statement on this page is drawn from the sources below. Our prices are shown live from our pharmacy's product listings, and competitor prices show the date they were collected.
Sources — 6 references
- NICE TA1026 — Tirzepatide for managing overweight and obesity, including the practical prescribing guide
- NHS England — Weight management injections: rollout guidance
- Mounjaro KwikPen — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- MHRA — guidance on contraception with GLP-1/GIP medicines; counterfeit medicine alerts and Yellow Card scheme
- Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). N Engl J Med 2025
- Wegovy — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC)
EverydayMeds is operated by OVIO Ltd · GPhC-registered pharmacy 9012878 · Registered premises, Leicester · Superintendent Pharmacist: Mahommed Zunaid Ayub Patel


